"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"

Last updated: July 29, 2021
Sponsor: Medical University of Gdansk
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Colon Cancer; Rectal Cancer

Gastric Cancer

Rectal Cancer

Treatment

N/A

Clinical Study ID

NCT04980950
MUG
  • Ages 18-80
  • All Genders

Study Summary

Enteral immunomodulating nutrition modifies the gastrointestinal microbiota as well as improves the intestinal barrier integrity in patients with gastric and colorectal cancer in the perioperative period. As a consequence, it contributes to the reduction of the incidence of postoperative complications and diarrhea, which is a side effect of anti-cancer treatment often used preoperatively in this group of cancers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age >18 y.o.
  • patients with gastric or colorectal cancer
  • patients treated in Department of Surgical Oncology, Medical University of Gdańsk
  • patients' agreement to take part in this study

Exclusion

Exclusion Criteria:

  • age <18 y.o.
  • other types of cancer than gastric/colorectal cancer
  • the presence of inflammatory bowel disease
  • pregnancy

Study Design

Total Participants: 80
Study Start date:
August 01, 2021
Estimated Completion Date:
July 01, 2022